{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:54:13Z","timestamp":1761807253648,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology Nursing"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.soncn.2006.04.007","type":"journal-article","created":{"date-parts":[[2006,8,8]],"date-time":"2006-08-08T12:46:58Z","timestamp":1155041218000},"page":"144-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Chemotherapy and Cutaneous Toxicities: Implications for Oncology Nurses"],"prefix":"10.1016","volume":"22","author":[{"given":"Pamela Hallquist","family":"Viale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.soncn.2006.04.007_bib1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00001622-200203000-00012","article-title":"Cutaneous toxicities of cancer therapy","volume":"14","author":"Alley","year":"2002","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.soncn.2006.04.007_bib2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/1120009X.1994.11741178","article-title":"Dermatological toxicity from chemotherapy containing 5-fluorouracil","volume":"6","author":"Leo","year":"1994","journal-title":"J Chemother"},{"key":"10.1016\/j.soncn.2006.04.007_bib3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1517\/14740338.3.6.579","article-title":"Mucocutaneous side effects of antineoplastic chemotherapy","volume":"3","author":"Guillot","year":"2004","journal-title":"Expert Opin Drug Safety"},{"key":"10.1016\/j.soncn.2006.04.007_bib4","first-page":"1417","article-title":"Nail abnormalities","volume":"69","author":"Fawcett","year":"2004","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.soncn.2006.04.007_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/annonc\/mdg050","article-title":"Taxane-induced nail changes","volume":"14","author":"Minisini","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.soncn.2006.04.007_bib6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1188\/04.CJON.527-528","article-title":"Chemotherapy-induced nail changes","volume":"8","author":"Marrs","year":"2004","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.soncn.2006.04.007_bib7","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1200\/JCO.2003.04.169","article-title":"Case 2","volume":"21","author":"Monti","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.04.007_bib8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1470-2045(05)70243-6","article-title":"Cutaneous side-effects of kinase inhibitors and blocking antibodies","volume":"6","author":"Robert","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.soncn.2006.04.007_bib9","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2367::AID-CNCR22>3.0.CO;2-#","article-title":"Onycholysis as a complication of systemic chemotherapy","volume":"88","author":"Hussain","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.soncn.2006.04.007_bib10","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1200\/JCO.2005.15.651","article-title":"Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand","volume":"23","author":"Scotte","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.04.007_bib11","unstructured":"Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events v3.0. Rockville, MD, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Department of Health and Human Services. June 10, 2003."},{"key":"10.1016\/j.soncn.2006.04.007_bib12","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMicm041166","article-title":"Bortezomib-induced skin lesions","volume":"352","author":"Agterof","year":"2005","journal-title":"N Engl J Med"},{"year":"2005","series-title":"Chemotherapy and Biotherapy Guidelines and Recommendations for Practice","author":"Polovich","key":"10.1016\/j.soncn.2006.04.007_bib13"},{"key":"10.1016\/j.soncn.2006.04.007_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/09546630510026724","article-title":"Cutaneous photosensitivity induced by paclitaxel and trastuzumab therapy associated with aberrations in the biosynthesis of porphyrins","volume":"16","author":"Cohen","year":"2005","journal-title":"J Derm Treat"},{"key":"10.1016\/j.soncn.2006.04.007_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1188\/05.CJON.103-106","article-title":"Palmar-plantar erythrodysesthesia","volume":"9","author":"Wilkes","year":"2005","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.soncn.2006.04.007_bib16","first-page":"138b","article-title":"Celecoxib attenuated capecitabine induced hand and foot syndrome (HFS) and diarrhea and improved time to tumor progression in metastatic colorectal cancer","volume":"21","author":"Lin","year":"2002","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.soncn.2006.04.007_bib17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00000421-200212000-00015","article-title":"Acral erythrodysesthesia caused by intravenous infusion of docetaxel in breast cancer","volume":"25","author":"Eich","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.soncn.2006.04.007_bib18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1046\/j.1365-4362.1997.00040.x","article-title":"Chemotherapy-induced acral erythema in leukemic patients","volume":"36","author":"Demircay","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.soncn.2006.04.007_bib19","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1046\/j.1525-1470.1999.00105.x","article-title":"Acral erythema in children receiving high-dose methotrexate","volume":"16","author":"Millot","year":"1999","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.soncn.2006.04.007_bib20","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1188\/05.ONF.1027-1035","article-title":"Chemotherapy-induced hypersensitivity reactions","volume":"32","author":"Gobel","year":"2005","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.soncn.2006.04.007_bib21","first-page":"161","article-title":"Hypersensitivity reactions to chemotherapy drugs","volume":"15","author":"Gonzalez","year":"2000","journal-title":"Alergol Immunol Clin"},{"key":"10.1016\/j.soncn.2006.04.007_bib22","series-title":"Cancer Medicine","article-title":"Dermatologic complications of cancer chemotherapy","author":"Apisarnthanarax","year":"2000"},{"key":"10.1016\/j.soncn.2006.04.007_bib23","first-page":"531","article-title":"Chemotherapy extravasation from implanted ports","volume":"27","author":"Schulmeister","year":"2000","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.soncn.2006.04.007_bib24","unstructured":"Mandanas RA. Graft versus host disease: E Medicine. Available at: http:\/\/www.emedicine.com\/med\/topic926.htm. (accessed June 8, 2006)."},{"key":"10.1016\/j.soncn.2006.04.007_bib25","first-page":"47","article-title":"Diagnosing graft versus host disease","volume":"4","author":"O\u2019Rourke","year":"2000","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.soncn.2006.04.007_bib26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1634\/theoncologist.10-5-345","article-title":"HER1\/EGFR inhibitor-associated rash","volume":"10","author":"Perez-Soler","year":"2005","journal-title":"Oncologist"}],"container-title":["Seminars in Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208106000611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208106000611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:35:33Z","timestamp":1760070933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749208106000611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0749208106000611"],"URL":"https:\/\/doi.org\/10.1016\/j.soncn.2006.04.007","relation":{},"ISSN":["0749-2081"],"issn-type":[{"type":"print","value":"0749-2081"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemotherapy and Cutaneous Toxicities: Implications for Oncology Nurses","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soncn.2006.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}